PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Samsara Inc. (IOT)
33.600.80 (-2.33%)
33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
13.43%
Revenue growth at 50-75% of S's 19.23%. Martin Whitman would worry about competitiveness or product relevance.
18.36%
Gross profit growth at 75-90% of S's 23.51%. Bill Ackman would demand operational improvements to match competitor gains.
72.53%
Positive EBIT growth while S is negative. John Neff might see a substantial edge in operational management.
72.53%
Positive operating income growth while S is negative. John Neff might view this as a competitive edge in operations.
71.92%
Positive net income growth while S is negative. John Neff might see a big relative performance advantage.
84.62%
Positive EPS growth while S is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
84.62%
Positive diluted EPS growth while S is negative. John Neff might view this as a strong relative advantage in controlling dilution.
82.78%
Slight or no buybacks while S is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
82.78%
Slight or no buyback while S is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
-0.99%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-3.02%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-25.39%
Negative 10Y revenue/share CAGR while S stands at 247.81%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-25.39%
Negative 5Y CAGR while S stands at 247.81%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-25.39%
Negative 3Y CAGR while S stands at 247.81%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
39.61%
Positive long-term OCF/share growth while S is negative. John Neff would see a structural advantage in sustained cash generation.
39.61%
Positive OCF/share growth while S is negative. John Neff might see a comparative advantage in operational cash viability.
39.61%
Positive 3Y OCF/share CAGR while S is negative. John Neff might see a big short-term edge in operational efficiency.
15.25%
Positive 10Y CAGR while S is negative. John Neff might see a substantial advantage in bottom-line trajectory.
15.25%
Positive 5Y CAGR while S is negative. John Neff might view this as a strong mid-term relative advantage.
15.25%
Positive short-term CAGR while S is negative. John Neff would see a clear advantage in near-term profit trajectory.
6.09%
Below 50% of S's 5794.20%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
6.09%
Below 50% of S's 5794.20%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
6.09%
Below 50% of S's 5794.20%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.50%
Our AR growth while S is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
26.99%
We show growth while S is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-1.46%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-46.76%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-4.00%
We’re deleveraging while S stands at 3.59%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-67.59%
Our R&D shrinks while S invests at 7.59%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-38.21%
We cut SG&A while S invests at 36.80%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.